Mercer Global Advisors
VOR icon

Mercer Global Advisors’s Vor Biopharma VOR Stock Holding History

Mercer Global Advisors’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25K Buy
+68
New +$1.03K ﹤0.01% 5700

Other funds holding VOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mercer Global Advisors's VOR Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Vor Biopharma (VOR) in Q2 2026: 68 shares worth $1.25K. The stake represents ﹤0.01% of the portfolio and ranks #5700 among its holdings.

51 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Mercer Global Advisors held 68 shares of Vor Biopharma worth $1.25K as of Q2 2026.
  • Vor Biopharma was a new Mercer Global Advisors position in Q2 2026.
  • Vor Biopharma made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5700 holding.
  • 51 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.